• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胶质母细胞瘤患者的生存预后因素:我们的经验。

Survival prognostic factors in patients with glioblastoma: our experience.

作者信息

Raysi Dehcordi S, De Paulis D, Marzi S, Ricci A, Cimini A, Cifone M G, Galzio R J

机构信息

Department of Health Sciences, University of L'Aquila, L'Aquila, Italy.

出版信息

J Neurosurg Sci. 2012 Sep;56(3):239-45.

PMID:22854592
Abstract

AIM

Approximate survival for glioblastoma is less than 1 year. Age, histological features and performance status at presentation represent the three statistically independent factors affecting longevity. The purpose of the study was to assess the role of surgery and to analyze prognostic factors in our patients operated for glioblastoma.

METHODS

We evaluated in 56 patients operated for glioblastoma their depressive and performance status in the preoperative and postoperative time. Moreover we analyzed the extent of surgery, the site and the size of lesions.

RESULTS

Median overall survival was 17 months. An age of ≥60 years (P<0.03), a preoperative Karnofsky Performance Status KPS≤70 (P=0.04), a subtotal tumor resection (P<0.001), a tumor size >5 cm (P=0.01), and no postoperative adjuvant treatment (P=0.01) were associated with the worst prognosis. Before surgery we found the presence of depression in 10 patients with a significative reduction of mean Back Depression Inventory scores after tumor resection (P=0.03). Finally, a KPS≤70 was significantly associated with an increased incidence of depression in the postoperative time.

CONCLUSION

Tumor size, total resection and affective disorders were identified as predictors of survival in our series of patients with glioblastoma in addition to age and KPS score. In our opinion an early diagnosis and the use of specific safeguards in the operating room contribute to have an extension of the tumor progression time and median survival.

摘要

目的

胶质母细胞瘤的近似生存期不到1年。就诊时的年龄、组织学特征和功能状态是影响生存期的三个统计学上独立的因素。本研究的目的是评估手术的作用,并分析我们收治的接受胶质母细胞瘤手术患者的预后因素。

方法

我们评估了56例接受胶质母细胞瘤手术患者术前和术后的抑郁及功能状态。此外,我们分析了手术范围、病变部位和大小。

结果

总生存期的中位数为17个月。年龄≥60岁(P<0.03)、术前卡氏功能状态评分(KPS)≤70(P=0.04)、肿瘤次全切除(P<0.001)、肿瘤大小>5 cm(P=0.01)以及未进行术后辅助治疗(P=0.01)与最差预后相关。术前我们发现10例患者存在抑郁,肿瘤切除后平均背部抑郁量表评分显著降低(P=0.03)。最后,KPS≤70与术后抑郁发生率增加显著相关。

结论

除年龄和KPS评分外,肿瘤大小、全切除及情感障碍被确定为我们这组胶质母细胞瘤患者生存的预测因素。我们认为早期诊断以及在手术室采取特定的防护措施有助于延长肿瘤进展时间和中位生存期。

相似文献

1
Survival prognostic factors in patients with glioblastoma: our experience.胶质母细胞瘤患者的生存预后因素:我们的经验。
J Neurosurg Sci. 2012 Sep;56(3):239-45.
2
Glioblastoma in the elderly: the effect of aggressive and modern therapies on survival.老年胶质母细胞瘤:积极和现代治疗方法对生存的影响。
J Neurosurg. 2016 Apr;124(4):998-1007. doi: 10.3171/2015.4.JNS142200. Epub 2015 Oct 9.
3
Quality of survival the 1st year with glioblastoma: a longitudinal study of patient-reported quality of life.胶质母细胞瘤患者第一年的生存质量:一项关于患者报告的生活质量的纵向研究。
J Neurosurg. 2016 Apr;124(4):989-97. doi: 10.3171/2015.4.JNS15194. Epub 2015 Oct 2.
4
Effectiveness of temozolomide treatment used at the same time with radiotherapy and adjuvant temozolomide; concomitant therapy of glioblastoma multiforme: multivariate analysis and other prognostic factors.替莫唑胺与放疗同时使用及辅助替莫唑胺治疗的有效性;多形性胶质母细胞瘤的同步治疗:多因素分析及其他预后因素
J Neurosurg Sci. 2010 Mar;54(1):7-19.
5
Risk factors for glioblastoma therapy associated complications.胶质母细胞瘤治疗相关并发症的危险因素。
Clin Neurol Neurosurg. 2015 Jul;134:55-9. doi: 10.1016/j.clineuro.2015.01.006. Epub 2015 Jan 9.
6
Perioperative quality of life in functionally dependent glioblastoma patients: A prospective study.功能依赖型胶质母细胞瘤患者围手术期的生活质量:一项前瞻性研究。
Br J Neurosurg. 2015;29(6):843-9. doi: 10.3109/02688697.2015.1054355. Epub 2015 Jun 22.
7
The relative value of postoperative versus preoperative Karnofsky Performance Scale scores as a predictor of survival after surgical resection of glioblastoma multiforme.术后与术前卡诺夫斯基功能状态评分作为多形性胶质母细胞瘤手术切除后生存预测指标的相对价值。
J Neurooncol. 2015 Jan;121(2):359-64. doi: 10.1007/s11060-014-1640-x. Epub 2014 Oct 26.
8
Effectiveness of maximal safe resection for glioblastoma including elderly and low Karnofsky performance status patients: retrospective review at a single institute.胶质母细胞瘤最大安全切除的有效性,包括老年和低卡诺夫斯基功能状态患者:单机构回顾性研究
Neurol Med Chir (Tokyo). 2012;52(8):570-6. doi: 10.2176/nmc.52.570.
9
Infarct volume after glioblastoma surgery as an independent prognostic factor.胶质母细胞瘤手术后的梗死体积作为一个独立的预后因素。
Oncotarget. 2016 Sep 20;7(38):61945-61954. doi: 10.18632/oncotarget.11482.
10
Surgical treatment of glioblastoma in the elderly: the impact of complications.老年人胶质母细胞瘤的手术治疗:并发症的影响。
J Neurooncol. 2018 May;138(1):123-132. doi: 10.1007/s11060-018-2777-9. Epub 2018 Feb 1.

引用本文的文献

1
Prognostic Factors of Survival in Glioblastoma Multiforme Patients-A Retrospective Study.多形性胶质母细胞瘤患者生存的预后因素——一项回顾性研究
Diagnostics (Basel). 2022 Oct 30;12(11):2630. doi: 10.3390/diagnostics12112630.
2
Symptoms of Depression and Anxiety in Adults with High-Grade Glioma: A Literature Review and Findings in a Group of Patients before Chemoradiotherapy and One Year Later.高级别胶质瘤成年患者的抑郁和焦虑症状:文献综述及一组患者放化疗前和一年后的研究结果
Cancers (Basel). 2022 Oct 22;14(21):5192. doi: 10.3390/cancers14215192.
3
Determining the applicability of the RSNA radiology lexicon (RadLex) in high-grade glioma MRI reporting-a preliminary study on 20 consecutive cases with newly diagnosed glioblastoma.
确定RSNA放射学词汇表(RadLex)在高级别胶质瘤MRI报告中的适用性——对20例新诊断胶质母细胞瘤连续病例的初步研究
BMC Med Imaging. 2022 Mar 24;22(1):53. doi: 10.1186/s12880-022-00776-8.
4
Prognostic and Predictive Factors in Elderly Patients With Glioblastoma: A Single-Center Retrospective Study.老年胶质母细胞瘤患者的预后和预测因素:一项单中心回顾性研究。
Front Aging Neurosci. 2022 Jan 31;13:777962. doi: 10.3389/fnagi.2021.777962. eCollection 2021.
5
Peritumoral edema status of glioblastoma identifies patients reaching long-term disease control with specific progression patterns after tumor resection and high-dose proton boost.脑胶质母细胞瘤瘤周水肿状态可识别出在肿瘤切除和高剂量质子治疗后具有特定进展模式并获得长期疾病控制的患者。
J Cancer Res Clin Oncol. 2021 Dec;147(12):3503-3516. doi: 10.1007/s00432-021-03765-6. Epub 2021 Aug 30.
6
Trends in glioblastoma: outcomes over time and type of intervention: a systematic evidence based analysis.胶质母细胞瘤的趋势:随时间和干预类型的变化的结果:一项系统的基于证据的分析。
J Neurooncol. 2020 Apr;147(2):297-307. doi: 10.1007/s11060-020-03451-6. Epub 2020 Mar 9.
7
Health-related quality of life and psychological functioning in patients with primary malignant brain tumors: a systematic review of clinical, demographic and mental health factors.原发性恶性脑肿瘤患者的健康相关生活质量和心理功能:对临床、人口统计学和心理健康因素的系统评价
Neurooncol Pract. 2016 Dec;3(4):211-221. doi: 10.1093/nop/npv042. Epub 2015 Oct 23.
8
Impact of standard care on elderly glioblastoma patients.标准治疗对老年胶质母细胞瘤患者的影响。
Neurooncol Pract. 2017 Mar;4(1):4-14. doi: 10.1093/nop/npw011. Epub 2016 Dec 9.
9
Evidence and context of use for contrast enhancement as a surrogate of disease burden and treatment response in malignant glioma.对比增强作为恶性胶质瘤疾病负担和治疗反应替代指标的证据和应用背景。
Neuro Oncol. 2018 Mar 27;20(4):457-471. doi: 10.1093/neuonc/nox193.
10
The role of brachytherapy in the treatment of glioblastoma multiforme.近距离放射疗法在多形性胶质母细胞瘤治疗中的作用。
Neurosurg Rev. 2017 Apr;40(2):195-211. doi: 10.1007/s10143-016-0727-6. Epub 2016 May 16.